Truex Paul F's Form 4 filing
Milestone Pharmaceuticals Inc. (MIST) · filed Jun 1, 2022
- Accession no.
- 0001209191-22-033336
- Filed
- Jun 1, 2022
- Trade date
- May 31, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market purchases total $28.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Truex Paul FCIK 0001120362 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | Common Shares | MOption exerciseAcquired | +8,016 | $1.12 | +$8,977.92 | 8,016 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseAcquired | +45,072 | $1.54 | +$69,410.88 | 53,088 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseAcquired | +22,870 | $1.54 | +$35,219.8 | 75,958 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseAcquired | +822 | $2.66 | +$2,186.52 | 76,780 | Direct | |
| May 31, 2022 | Common Shares | PPurchaseAcquired | +5,000 | $5.60 | +$28,000 | 81,780 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | Common Shares | MOption exerciseDisposed | −8,016 | $0.00 | $0 | 0 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseDisposed | −45,072 | $0.00 | $0 | 0 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseDisposed | −22,870 | $0.00 | $0 | 2,659 | Direct | |
| May 31, 2022 | Common Shares | MOption exerciseDisposed | −822 | $0.00 | $0 | 117 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.